United States Biotechnology & Medical Research

Grace Therapeutics, Inc (GRCE)

Track

Track

Grace Therapeutics, Inc. recorded insider buying activity during August and September 2023. Director Vimal Kavuru acquired 1,352,742 shares, while Donald John Olds purchased 762 units. These transactions represent the most recent documented activity, occurring over three months ago. No further trades have been reported since that period.
Ticker: GRCE Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Grace Therapeutics, Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.2
Kavuru, Vimal Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
304.11
Quantity 29,490 +34.1%
Value US$805,563
3.2
Kavuru Vimal Non-Executive Director Large shareholder
Transaction date
Purchase
Price
207.80
Quantity 57,597 +47.9%
Value US$4,985,886
3.8
Olds, Donald John Director of Issuer Non-Executive Director
Transaction date
Purchase
Price
351.87
Quantity 29,536
Value US$4,227,358
3.0
Olds Donald Non-Executive Director
Transaction date
Purchase
Price
2.05
Quantity 381 +inf%
Value US$781
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-09-28 2023-09-25 B Purchase
3.2
Kavuru, Vimal

Director of Issuer

Non-Executive Director
29,490 +34.1%
304.11
US$805,563 		29,490 +34.1% 304.11 US$805,563
2023-09-27 2023-09-25 B Purchase
3.2
Kavuru Vimal
Non-Executive Director Large shareholder
57,597 +47.9%
207.80
US$4,985,886 		57,597 +47.9% 207.80 US$4,985,886
2023-09-05 2023-08-31 B Purchase
3.8
Olds, Donald John

Director of Issuer

Non-Executive Director
29,536
351.87
US$4,227,358 		29,536 351.87 US$4,227,358
2023-09-05 2023-08-31 B Purchase
3.0
Olds Donald
Non-Executive Director
381 +inf%
2.05
US$781 		381 +inf% 2.05 US$781
Explore more

More insider trading research around Grace Therapeutics, Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America